 | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C14H19NO |
| Molar mass | 217.312 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4'-Methyl-α-pyrrolidinopropiophenone (4-MePPP,MPPP orMαPPP) is astimulant drug andsubstituted cathinone. It is structurally very similar toα-PPP, with only one added methyl group in the para position on the phenyl ring. 4-MePPP was sold in Germany as adesigner drug in the late 1990s and early 2000s,[2][3][4] along with a number of otherpyrrolidinophenone derivatives.[5][6] Although it has never achieved the same international popularity as its better-known relations α-PPP andMDPV, 4-MePPP is still sometimes found as an ingredient of grey-market "bath salt" blends[7] such as "NRG-3".[7]
4-MePPP is unscheduled in the United States, but could be consider an analogue ofMephedrone or another scheduled cathinone, which would make it schedule 1 when sold for human consumption due to theFederal Analogue Act[8]
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |
